FONT-SIZE Plus   Neg

Regeneron Pharmaceuticals (REGN) Rose To A New High For The Year

Regeneron Pharmaceuticals (REGN) traded to the upside throughout the first half of Wednesday's session and took out the highs of the day going into the close. The stock finished with a gain of 10.05 at $201.13.

Regeneron Pharmaceuticals has been gaining ground for nearly 2 weeks and set a new high for the year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
Trade REGN now with 
Follow RTT